(±) -Iroxanadine
(±) -Iroxanadine (BRX 005; BRX 235), a vasculoprotector, is a p38 kinase and HSP protein activator. (±) -Iroxanadine has the potential for atherosclerosis and vascular diseases research[1].
Product Specifications
CAS Number
203805-20-3
Product Name Alternative
BRX 005; BRX 235
UNSPSC
12352005
Target
HSP; p38 MAPK
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage; MAPK/ERK Pathway; Metabolic Enzyme/Protease
Applications
Neuroscience-Neuromodulation
Field of Research
Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/racemic-iroxanadine.html
Solubility
10 mM in DMSO
Smiles
C1(C2=CC=CN=C2)=NOCC(CN3CCCCC3)N1
Molecular Formula
C14H20N4O
Molecular Weight
260.33
References & Citations
[1]A E Kabakov, et al. Pharmacological attenuation of apoptosis in reoxygenated endothelial cells. Cell Mol Life Sci. 2004 Dec;61 (24) :3076-86.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
